News

Axxess Pharma claimed that it would also be the first company to introduce a unique herbal, non-alcohol based antiseptic hand wash and disinfectant to the Canadian market. Axxess

Levetiracetam injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. It is also indicated as adjunctive therapy in the treatment

Aveo said that the patents cover two different diagnostic tests for identifying human patients likely to respond to treatment with tivozanib, company’s selective inhibitor of VEGF receptors 1,

The collaboration further expands Qiagen’s testing portfolio for the early detection of diseases and individualised treatment of patients thereby strengthening Qiagen’s molecular diagnostics offering for applications in prevention

Titan Pharmaceuticals is the assignee of this patent which claims a method for treating opiate addiction with a subcutaneously implanted device comprising buprenorphine and ethylene vinyl acetate, a

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a dry powder topical tissue sealant in development to stop bleeding

The BD Bactec MGIT 320 system is half the physical size of the BD Bactec MGIT 960 system, a fully automated system for mycobacterial liquid culture and susceptibility

Biotivia claimed that Florativia is the world’s first supplement combining both prebiotics and probiotics in one Twist ‘n Shake bottle. According to Florativia its new packaging technology separates

Mr Madsen joined Novavax in 2008 as director of BioProcess Development with responsibility for development of Novavax’s seasonal and pandemic influenza vaccines for clinical testing. Earlier, he was